Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Tempur Sealy Settles With Hedge Fund H Partners After CEO Ouster also written by Antoine Gara
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Amazon's Board Diversity Push Could Destroy Traditional Retail also categorized in BoardMoves
- Warren Buffett And CalSTRS Agree On Brian Moynihan's Performance At Bank Of America also written by Antoine Gara
- No Sleep Till Activism: Hedge Fund H Partners Wins Mattress Company Fight also written by Antoine Gara
- Berkshire Hathaway Wannabe Turning Into A Quagmire For Investors also written by Antoine Gara
- Twitter's Jack Dorsey To Join Disney Board Of Directors also categorized in BoardMoves
Login to comment.